UNIDO: Long-term support for biotech yields COVID-19 vaccine promise in Cuba
The Cuban government recently announced that its Soberana II vaccine against COVID-19 will soon enter Phase III trials, bringing the country one important step closer to producing Latin America’s first vaccine against the virus. Far from being an overnight success, Cuba’s ability to develop a vaccine is the result of decades-long investment in its biopharmaceutical industry, which in its early stages of development was supported by the United Nations Industrial Development Organization (UNIDO).